In a new filing with the Securities and Exchange Commission, Bain Capital‘s Brookside Capital disclosed increasing its activist stake in PTC Therapeutics......
(read more)October 16 - Hedge Funds, News - Comments
As a new filing with the Securities and Exchange Commission showed today, Samuel Isaly‘s Orbimed Advisors have trimmed its exposure to Relypsa Inc......
(read more)September 19 - Hedge Funds, News - Comments
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission. For the second quarter of 2014......
(read more)August 28 - Hedge Funds, News - Comments
Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT). According to the filing, Orbimed......
(read more)August 28 - Hedge Funds, News - Comments
Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares......
(read more)August 12 - Hedge Funds, News - Comments
Over the past week, a few multi millionaire insider purchases caught my eye. In this article, I will look into three particular companies that saw their......
(read more)June 10 - Hedge Funds, Insider Trading - Comments
Samuel Isaly‘s Orbimed Advisors is one of the largest hedge funds focused almost entirely on the healthcare sector. In a recent intervention on......
(read more)March 6 - Hedge Funds, News - Comments
Peter Kolchinsky‘s hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more.......
(read more)November 22 - Hedge Funds, News - Comments
RA Capital, Achillion Pharmaceuticals: In a 13G filing with the SEC, Peter Kolchinsky‘s RA Capital disclosed that it owns nearly 15% of infectious......
(read more)October 4 - Hedge Funds, News - Comments
At the moment, there are plenty of methods shareholders can use to track stocks. Two of the most underrated are hedge fund and insider trading movement......
(read more)September 17 - News - Comments
Is Theravance Inc (NASDAQ:THRX) a good investment? At the moment, there are many indicators investors can use to analyze stocks. Some of the most under......
(read more)September 12 - News - Comments
To many of your fellow Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) investors, hedge funds are perceived as overrated, outdated investment......
(read more)September 11 - News - Comments
Is Akorn, Inc. (NASDAQ:AKRX) a buy? To many of your peers, hedge funds are viewed as useless, old investment tools of an era lost to time. Although there......
(read more)September 11 - News - Comments
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment......
(read more)September 10 - News - Comments
As fast as we can type this, Phill Gross and Robert Atchinson’s hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares......
(read more)September 9 - News - Comments
Is Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) a good investment? In the 21st century investor’s toolkit, there are plenty of indicators market participants......
(read more)September 6 - News - Comments
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial......
(read more)September 4 - News - Comments
Should Perrigo Company (NYSE:PRGO) investors track the following data? In the eyes of many traders, hedge funds are perceived as useless, outdated financial......
(read more)September 3 - News - Comments
To the average investor, there are a multitude of methods shareholders can use to monitor publicly traded companies. A duo of the most underrated are......
(read more)September 3 - News - Comments
What’s a smart InterMune Inc (NASDAQ:ITMN) investor to do? To many market players, hedge funds are perceived as delayed, old financial tools of......
(read more)September 3 - News - Comments
What’s a smart HeartWare International Inc (NASDAQ:HTWR) investor to do? In the 21st century investor’s toolkit, there are plenty of metrics......
(read more)September 3 - News - Comments
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age. Although there are over 8,000......
(read more)September 3 - News - Comments
If you were to ask many investors, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times. Although there......
(read more)September 3 - News - Comments
To the average investor, there are many gauges shareholders can use to analyze the equity markets. Some of the most innovative are hedge fund and insider......
(read more)September 2 - News - Comments
Is it smart to be bullish on Sequenom, Inc. (NASDAQ:SQNM)? If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles......
(read more)August 30 - News - Comments
Is Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a good investment? To the average investor, there are dozens of indicators market participants can use......
(read more)August 30 - News - Comments
Should a DexCom, Inc. (NASDAQ:DXCM) investor track the following data? If you were to ask many traders, hedge funds are assumed to be overrated, old......
(read more)August 30 - News - Comments
What’s a smart OraSure Technologies, Inc. (NASDAQ:OSUR) investor to do? In the eyes of many traders, hedge funds are viewed as delayed, old financial......
(read more)August 30 - News - Comments
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use......
(read more)August 30 - News - Comments
To many of your peers, hedge funds are perceived as overrated, old investment tools of a period lost to current times. Although there are over 8,000 hedge......
(read more)August 29 - News - Comments
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge......
(read more)August 29 - News - Comments
Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a good investment? If you were to ask many investors, hedge funds are viewed as delayed, outdated investment......
(read more)August 29 - News - Comments
Is Varian Medical Systems, Inc. (NYSE:VAR) a good investment? In the financial world, there are a multitude of indicators investors can use to track......
(read more)August 28 - News - Comments
To many traders, hedge funds are perceived as delayed, outdated investment vehicles of an era lost to time. Although there are In excess of 8,000 hedge......
(read more)August 28 - News - Comments
In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and......
(read more)August 28 - News - Comments
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies. A pair of the most innovative are hedge......
(read more)August 28 - News - Comments
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in......
(read more)August 28 - News - Comments
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a buy? In the 21st century investor’s toolkit, there are tons of metrics market participants can......
(read more)August 26 - News - Comments
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use......
(read more)August 26 - News - Comments
In the 21st century investor’s toolkit, there are many indicators market participants can use to watch stocks. A couple of the best are hedge fund and......
(read more)August 26 - News - Comments
Is Allergan, Inc. (NYSE:AGN) a buy? In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost......
(read more)August 26 - News - Comments
Should you be crazy about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)? In the financial world, there are dozens of gauges shareholders can use to analyze......
(read more)August 26 - News - Comments
Is Mylan Inc. (NASDAQ:MYL) a buy? To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time. Although......
(read more)August 25 - News - Comments
Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.......
(read more)August 25 - News - Comments
Is Amarin Corporation plc (ADR) (NASDAQ:AMRN) a buy? In the financial world, there are many metrics shareholders can use to track their holdings. A duo......
(read more)August 23 - News - Comments
Eli Lilly & Co. (NYSE:LLY) investors likely know every metric that’s typically discussed in relation to the healthcare giant, but we’ll......
(read more)August 23 - Dividend Stocks, News - Comments
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times. Although there are more......
(read more)August 23 - News - Comments
Boston Scientific Corporation (NYSE:BSX) investors: listen up. If you were to ask many investors, hedge funds are viewed as useless, old investment vehicles......
(read more)August 22 - News - Comments
Merck & Co., Inc. (NYSE:MRK) has had a consistently swell 2013, and the hits just keep on coming. Now, according to many investors, hedge funds are......
(read more)August 21 - News - Comments
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds’ portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest......
(read more)August 13 - News - Comments
